R&D Should Be Outsourced Overseas To Control Development Costs – HGS CEO
Drug companies should consider outsourcing R&D work to other countries in light of cost pressures in the U.S., Human Genome Sciences CEO William Haseltine, PhD, said
Drug companies should consider outsourcing R&D work to other countries in light of cost pressures in the U.S., Human Genome Sciences CEO William Haseltine, PhD, said